Curia Global, Inc.
Curia is a global contract research, development, and manufacturing organization with over 30 years of experience. It offers services across drug discovery, development, manufacturing, and biologics, backed by scientific expertise and a global network of facilities. Curia aims to accelerate the delivery of therapies to patients through flexible, scalable solutions and a commitment to quality and innovation.
Industries
Nr. of Employees
Very Large (1000+)
Curia Global, Inc.
Albany, New York, United States, North America
Services
Small‑molecule discovery and medicinal chemistry
Hit‑to‑lead discovery services including assay development, in‑vitro biology, medicinal chemistry, structural biology and computational design.
API process development and GMP manufacturing (small molecules)
Chemical process R&D, custom synthesis, high‑potency handling and GMP API production from kilograms to commercial scale.
Biologics discovery and antibody engineering
Antibody discovery, single‑cell screening, developability assessment, recombinant antibody production and cell engineering to progress programs into development.
mRNA and srRNA process development and GMP manufacture
mRNA and self‑replicating RNA process development, analytical support and GMP production, and downstream formulation into lipid nanoparticle systems.
Sterile drug product development and clinical/commercial fill–finish
Formulation development, process development, clinical and commercial sterile fill–finish, lyophilization and packaging for parenteral products.
Analytical testing, method development and stability programs
Method development and validation, batch release testing, stability studies and solid‑state chemistry to support regulatory submissions and product release.
Small‑molecule discovery and medicinal chemistry
Hit‑to‑lead discovery services including assay development, in‑vitro biology, medicinal chemistry, structural biology and computational design.
API process development and GMP manufacturing (small molecules)
Chemical process R&D, custom synthesis, high‑potency handling and GMP API production from kilograms to commercial scale.
Biologics discovery and antibody engineering
Antibody discovery, single‑cell screening, developability assessment, recombinant antibody production and cell engineering to progress programs into development.
mRNA and srRNA process development and GMP manufacture
mRNA and self‑replicating RNA process development, analytical support and GMP production, and downstream formulation into lipid nanoparticle systems.
Sterile drug product development and clinical/commercial fill–finish
Formulation development, process development, clinical and commercial sterile fill–finish, lyophilization and packaging for parenteral products.
Analytical testing, method development and stability programs
Method development and validation, batch release testing, stability studies and solid‑state chemistry to support regulatory submissions and product release.
Expertise Areas
- Clinical manufacturing and sterile fill–finish
- Small‑molecule process development and API manufacturing
- Biologics discovery, cell‑line development and bioprocessing
- mRNA and long‑RNA (srRNA) development and manufacture
Key Technologies
- GMP manufacturing
- Isolator‑based vial filling and automated fill–finish lines
- Lyophilization (freeze‑drying)
- Lipid nanoparticle (LNP) formulation